文献速递白血病淋巴瘤

热应激靶向并降解BCR::ABL1癌蛋白以克服费城染色体阳性急性淋巴细胞白血病的耐药

Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2025-07-22

本文报道热应激通过诱导液-固相变选择性破坏BCR::ABL1及其常见耐药突变体而不影响天然BCR和ABL蛋白,机制涉及激酶活性依赖的信号组分募集、卷曲螺旋结构域介导的寡聚化、c-Cbl介导的K27连接泛素化及蛋白酶体降解,体外抑制耐药白血病细胞增殖并在体内降低肿瘤负荷。

要点

  • 热应激选择性破坏BCR::ABL1及其常见耐药突变体,不影响天然BCR和ABL蛋白。
  • 机制为诱导液-固相变、信号复合物形成及c-Cbl介导K27泛素化-蛋白酶体降解。
  • 热应激体外抑制BCR::ABL1驱动的白血病细胞(含耐药突变体)增殖并在体内降低肿瘤负荷。

核心结论

  • 热应激通过诱导液-固相变选择性靶向并降解未突变及耐药突变型BCR::ABL1癌蛋白,为克服Ph+ ALL的TKI耐药提供了一种有前景的辅助策略。

研究设计与样本

  • 基础研究(体外细胞实验与体内实验),机制探索热应激对BCR::ABL1及其耐药突变体的作用。

主要发现

  • 热应激通过诱导液-固相变选择性破坏BCR::ABL1及其常见耐药突变体,而不影响天然BCR和ABL蛋白。
  • 热应激以激酶活性依赖方式促进BCR::ABL1信号组分(如SHIP2、Sts1、PI3K-p85α和Shc)募集,并通过卷曲螺旋结构域刺激BCR::ABL1寡聚化,形成大的热不稳定信号复合物。
  • 该过程触发由c-Cbl E3泛素连接酶介导的非经典K27连接泛素化,最终通过泛素-蛋白酶体途径导致BCR::ABL1降解。
  • 热应激在体外有效抑制BCR::ABL1驱动的白血病细胞(包括耐药突变体)增殖,并在体内降低肿瘤负荷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BCR::ABL1 oncofusion protein drives Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), making it a critical therapeutic target. Tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 have revolutionized the treatment of Ph+ ALL patients. However, mutations in the kinase domain of BCR::ABL1 commonly impair the sensitivity to TKIs, resulting in drug resistance and poor prognosis in Ph+ ALL. Here we report that heat stress selectively destabilizes BCR::ABL1 and its common drug-resistant mutants without affecting the native BCR and ABL proteins through inducing liquid-to-solid phase transition. Mechanistic studies revealed that heat stress facilitated recruitment of BCR::ABL1 signaling components (e.g., SHIP2, Sts1, PI3K-p85α and Shc) in a kinase activity dependent manner and stimulated BCR::ABL1 oligomerization through its coiled-coil domain, resulting in formation of a large, thermally unstable signaling complex. This process triggers non-canonical K27-linked ubiquitination mediated by c-Cbl E3 ubiquitin ligase, ultimately leading to BCR::ABL1 degradation via the ubiquitin-proteasome pathway. Functionally, heat stress effectively suppressed proliferation of BCR::ABL1-driven leukemia cells, including drug resistant mutants in vitro and decreased tumor burden in vivo. Our findings established that thermal-based therapy as a novel strategy to selectively target and degrade both unmutated and drug-resistant BCR::ABL1 oncoproteins, offering a promising adjuvant approach to overcome TKI resistance in Ph+ ALL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Yang C, Kang YY, Zhu CY, et al. Heat stress targets and degrades BCR::ABL1 oncoproteins to overcome drug-resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 2025. PMID: 40696139. doi:10.1038/s41375-025-02709-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。